Back to 
Zacks Investment Management
Zacks Investment Management
CORT
Showing 0 of 2 quarters
Position history for Zacks Investment Management's holdings in Corcept Therapeutics Incorporated
No. Zacks Investment Management exited its CORT (Corcept Therapeutics) position in Q2 2019. Its Q1 2019 13F listed 10,001 shares worth $117,000. Zacks Investment Management already held CORT in its Q1 2019 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.